Literature DB >> 9758411

Decreased interleukin-7 and transforming growth factor-beta1 levels in blister fluids as compared to the respective serum levels in patients with bullous pemphigoid. Opposite behavior of TNF-alpha, interleukin-4 and interleukin-10.

B Giacalone1, L D'Auria, C Bonifati, C Ferraro, E Riccardi, A Mussi, G D'Agosto, P Cordiali-Fei, F Ameglio.   

Abstract

This study analyzes both the blister fluid (BF) and serum levels of IL-7 and TGF-beta1 in samples from 18 patients affected with bullous pemphigoid (BP). These cytokines clearly present lower concentrations (P<0.001) in BFs than in the sera (1/20 and 1/2, respectively). In contrast, TNF-alpha, IL-10 and IL-4 present increased amounts in BFs that were 12, 12 and 17-fold, respectively. Eighteen sera (and 10 suction BF) from normal individuals were also employed as control. Normal sera presented significantly lower serum IL-7 concentrations than BP, while no significant TGF-beta1 variations were observed between normal and pathologic serum samples. In addition, the serum levels detected in BP patients were significantly correlated with disease intensity (r=0.64, P=0.003, evaluated as the number of blisters/erosions for each patient) as well as with the peripheral B-lymphocyte counts (r=0.80, P<0.001) and antibodies directed against the basement membrane zone (r=0.65, P<0.005). Although a clear explanation of this phenomenon is lacking, the data presented in this report agree with a strong decrease of IL-7 production at the local level (keratinocyte is known to produce IL-7 and the latter is known to be down-regulated by IL-10, and in other models also by TGF-beta1 and IL-4, whose levels are elevated in BP BFs) as opposed to an increased peripheral release of the same modulator. The IL-7 reduction may have a biological relevance in controlling a chronic, progressive disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9758411     DOI: 10.1111/j.1600-0625.1998.tb00317.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  5 in total

1.  Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype.

Authors:  Deirdre D Scripture-Adams; David G Brooks; Yael D Korin; Jerome A Zack
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature.

Authors:  Amy Attaway; Tracey L Mersfelder; Sakshi Vaishnav; Joanne K Baker
Journal:  J Dermatol Case Rep       Date:  2014-03-31

3.  Blister Fluid Induces MMP-9-Associated M2-Type Macrophages in Bullous Pemphigoid.

Authors:  Meriem Riani; Céline Muller; Camille Bour; Philippe Bernard; Frank Antonicelli; Sébastien Le Jan
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 7.561

Review 4.  Proteases in Pemphigoid Diseases.

Authors:  Sho Hiroyasu; Christopher T Turner; Katlyn C Richardson; David J Granville
Journal:  Front Immunol       Date:  2019-06-26       Impact factor: 7.561

5.  Potential implications of interleukin-7 in chronic wound healing.

Authors:  Annie Bartlett; Andrew J Sanders; Fiona Ruge; Keith G Harding; Wen G Jiang
Journal:  Exp Ther Med       Date:  2016-04-18       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.